Ruti Aga and the Prescription That Was Never Written: In a Six-Year Ban, the Paperwork Lost, Not the Drug

The Athletics Integrity Unit (AIU) statement released on Thursday contains a sentence that stops you cold: the person who signed the prescription was not a doctor at that clinic. He was a family member with no medical registration. The clinic whose stamp appeared on the document did not exist. And when asked where the prescription came from, the answer was "an old prescription pad left over from a former workplace." The same clinic stated in writing that it had never issued such a pad.

Three separate verifications. Three identical answers: no.

Ruti Aga has been banned for six years — two for the presence of a prohibited substance, four for tampering with evidence. The clock starts on 10 September, the date her provisional suspension began. The statement does not specify the year of that date, which is my first note, because a referee's habit is: do not put on the page what is not on the page.

Now the part where a great many reports slipped. Media called methylprednisolone a "prohibited steroid" and cited WADA classifying it as performance-enhancing. Technically, that is incomplete. Methylprednisolone is not an anabolic steroid; it is a glucocorticoid, class S9 on the WADA Prohibited List. And S9 carries different conditions: it is prohibited in-competition only, and only by injection, oral or rectal route. A therapeutic knee injection given out-of-competition is entirely legal.

So the whole case rested not on "steroid" but on route and timing. In road racing the testing window opens at 23:59 the night before the race. An injection given days earlier is still caught inside that window. This is the technical point without which the sanction looks absurd — and even with which it leaves a question open.

For twelve years I have stood at the edge of the field — first as a linesman in Bangalore district league matches at four hundred rupees a game, then at a VAR desk. In 2026, when I flagged an offside in a district under-19 final and the referee overruled me, I cut the clip into 96 frames overnight. I froze the frame, and the story changed. Aga's case demands the same: stop, and look at where the error actually happened.

The error is not in the drug. It is in the document. And the document's failure points at something larger — a medical arrangement that runs on paper rather than in a hospital.

Aga won a half marathon in China in March, and the sample was collected around that race. The time, the splits, the quality of the field — none of it is in the statement. The win tells us only that this was a World Athletics Label-tier elite field where testing happens. The spreadsheet was clean; the contest was not — meaning any comment on the performance itself would be dishonest.

Her record speaks differently. The 2026 Tokyo Marathon title is hers, along with three second-place finishes at World Marathon Majors. Berlin 2026, roughly 2:18:34 for second — that figure comes from external records, not the statement, so read it as context rather than proof. A 2:18 marathoner at 32 needs no further gloss.

Now the sanction arithmetic, which is the real substance of this story. Two years for presence, four for tampering, six in total. The arithmetic itself delivers a finding. Under the Code, a presence violation can be reduced if the athlete proves no fault or negligible fault. Two years tells us that relief was not granted. Four years tells us the tampering was treated as fully culpable.

There is a fine paradox here. A forged document is, by itself, evidence of an intent to conceal. Yet it did not escalate the presence sanction — it simply became a separate one. The panel weighed the two on separate scales, and Aga's side came up light both times.

Backdating to 10 September is no concession. Time served under provisional suspension counts against the ban, which means six years looks long on paper but had already begun. The athlete gains nothing from it. It is procedure, not mercy.

The statement does not say how far results were annulled. Standard AIU practice is that the result and prize money from the competition where the sample was collected are voided, along with ranking points accrued afterwards. That is inference, not stated fact — but it is so standard that the opposite is unlikely. The same March race, the same cheque, the same points.

The career maths is simple. Six years at 32 means a return at roughly 38. Ethiopia's women's marathon depth is such that even a 2:18 runner is not automatically selected. A two-year ban would merely have delayed her; six closes the door. The 2028 Olympic cycle sits entirely inside this sanction.

The root of this story is a knee, and the knee reads less like a single March event than a long-standing injury. Chronic knee pathology is the most common load-bearing failure in marathoners. The pressure to mask pain is sharpest there too, because the money arrives on appearance, not on form. A glucocorticoid is the cheapest, most available tool for suppressing that pain.

And here is the question the AIU statement does not touch: if the knee was genuinely treated, where is the record? Why would an athlete with a team physician, an understanding of the TUE process and a grasp of route-and-timing rules go and have a prescription forged? A forged prescription is produced where a real one was never written.

I have to place the counterintuitive part here, because the easiest report is the one that says: a cheating athlete was caught, six years is fair. That first reading should stand, and it is correct. But after it, something odd appears: the substance at the centre of the sanction has no proven endurance benefit. Yet the ban runs six years — longer than many EPO cases. The reason is not the drug; it is the paper. And that reason makes this a different kind of case, one that will be cited everywhere — by some as proof of AIU rigour, by others as proof of inconsistent enforcement against African road runners.

The second thing that stings: Aga closed off the one defence that had a genuine path. S9 applies only in-competition. Timing, route and medical necessity were all arguable — if the paperwork had been real. The forged prescription removed the argument before it could be made. That is the moment where the decision-making process lost, not the result.

The third point is bigger than one athlete. Over recent years a cluster of AIU cases has emerged in which the first charge concerns a substance and the second, heavier charge concerns the explanation document. The enforcement frontier has shifted from detection to document verification. China's label-race circuit is becoming the fastest zone for this: large appearance fees, deep East African elite fields and AIU testing all converging in the same race. The appearance-fee economy and the testing economy are colliding.

The fourth point deserves a question. The statement names only the family member. But no athlete has a forged prescription manufactured alone. Someone advises, someone carries the document, some manager or agent knows. Whether that was investigated is not disclosed. The crowd left, but the field kept testifying — there was simply nobody listening.

One thing survives, and it is Tokyo 2026. Absent a finding of earlier use, results before that date are not automatically annulled. That is emotional relief, not legal relief. On the spreadsheet the title is still recorded. In a sponsorship market where distance-running money is already thin, being recorded is not enough.

What next? Three things to watch. One, testing and document scrutiny will both tighten at Chinese label races, raising risk for the East African athletes who race there. Two, education on TUEs and medical records can no longer be a top-tier-only agenda; a 2:18 runner operating without a team doctor is the most uncomfortable fact in this file. Three, accountability for agents and management — as long as sanctions stop at the athlete, the system that produces forged prescriptions keeps running.

For me this case recalls the habit I learned while building a spreadsheet of 340 contested decisions: stop counting outcomes, start counting tells. The tells here are plain — no clinic, no doctor, no pad. Only the sanction was real, and it is. The question is not whether six years is too much or too little. The question is whether the next 32-year-old runner with a sore knee will have anywhere else to go.